{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:59:41Z","timestamp":1791820781624,"version":"4.3.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:00:00Z","timestamp":1736812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203756"],"award-info":[{"award-number":["82203756"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970456"],"award-info":[{"award-number":["81970456"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["xzy012023094"],"award-info":[{"award-number":["xzy012023094"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation Capability Support Program of Shaanxi","award":["2022PT-35"],"award-info":[{"award-number":["2022PT-35"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-025-00595-1","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T23:44:22Z","timestamp":1736811862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Elevated SREBP1 accelerates the initiation and growth of pancreatic cancer by targeting SOX9"],"prefix":"10.1186","volume":"20","author":[{"given":"Cancan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weikun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wunai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,14]]},"reference":[{"issue":"1","key":"595_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"595_CR2","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1038\/s41379-020-0629-6","volume":"33","author":"ED Thompson","year":"2020","unstructured":"Thompson ED, Roberts NJ, Wood LD, et al. The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go. Mod Pathol. 2020;33(12):2544\u201363.","journal-title":"Mod Pathol"},{"issue":"3","key":"595_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41568-021-00418-1","volume":"22","author":"AA Connor","year":"2022","unstructured":"Connor AA, Gallinger S. Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. Nat Rev Cancer. 2022;22(3):131\u201342.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"595_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ccell.2016.12.006","volume":"31","author":"CJ Halbrook","year":"2017","unstructured":"Halbrook CJ, Lyssiotis CA. Employing metabolism to improve the diagnosis and treatment of pancreatic Cancer. Cancer Cell. 2017;31(1):5\u201319.","journal-title":"Cancer Cell"},{"issue":"12","key":"595_CR5","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cac2.12360","volume":"42","author":"X Yin","year":"2022","unstructured":"Yin X, Xu R, Song J, et al. Lipid metabolism in pancreatic cancer: emerging roles and potential targets. Cancer Commun (Lond). 2022;42(12):1234\u201356.","journal-title":"Cancer Commun (Lond)"},{"issue":"4","key":"595_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cmet.2012.09.002","volume":"16","author":"W Shao","year":"2012","unstructured":"Shao W, Espenshade PJ. Expanding roles for SREBP in metabolism. Cell Metab. 2012;16(4):414\u20139.","journal-title":"Cell Metab"},{"key":"595_CR7","doi-asserted-by":"publisher","first-page":"952371","DOI":"10.3389\/fonc.2022.952371","volume":"12","author":"Q Zhao","year":"2022","unstructured":"Zhao Q, Lin X, Wang G, Targeting. SREBP-1-Mediated lipogenesis as potential strategies for Cancer. Front Oncol. 2022;12:952371.","journal-title":"Front Oncol"},{"key":"595_CR8","doi-asserted-by":"publisher","first-page":"1130747","DOI":"10.3389\/fphar.2023.1130747","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Wu S, Zhao X, et al. Key events in cancer: Dysregulation of SREBPs. Front Pharmacol. 2023;14:1130747.","journal-title":"Front Pharmacol"},{"issue":"5","key":"595_CR9","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1002\/ptr.7735","volume":"37","author":"C Guo","year":"2023","unstructured":"Guo C, Zhang L, Zhao M, et al. Targeting lipid metabolism with natural products: a novel strategy for gastrointestinal cancer therapy. Phytother Res. 2023;37(5):2036\u201350.","journal-title":"Phytother Res"},{"key":"595_CR10","doi-asserted-by":"publisher","first-page":"113920","DOI":"10.1016\/j.ejmech.2021.113920","volume":"227","author":"X Bai","year":"2022","unstructured":"Bai X, Ali A, Wang N, et al. Inhibition of SREBP-mediated lipid biosynthesis and activation of multiple anticancer mechanisms by platinum complexes: ascribe possibilities of new antitumor strategies. Eur J Med Chem. 2022;227:113920.","journal-title":"Eur J Med Chem"},{"issue":"1","key":"595_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13046-019-1288-7","volume":"38","author":"C Zhou","year":"2019","unstructured":"Zhou C, Qian W, Li J, et al. High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer. J Exp Clin Cancer Res. 2019;38(1):302.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"595_CR12","doi-asserted-by":"publisher","first-page":"e12514","DOI":"10.1111\/cpr.12514","volume":"52","author":"C Zhou","year":"2019","unstructured":"Zhou C, Qian W, Ma J, et al. Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1. Cell Prolif. 2019;52(1):e12514.","journal-title":"Cell Prolif"},{"key":"595_CR13","doi-asserted-by":"publisher","first-page":"111381","DOI":"10.1016\/j.cellsig.2024.111381","volume":"124","author":"R Cao","year":"2024","unstructured":"Cao R, Feng Z, Mo J, Wu J, Li J, Li W, et al. Pharmacological inhibition of SREBP1 suppresses pancreatic cancer growth via inducing GPX4-mediated ferroptosis. Cell Signal. 2024;124:111381.","journal-title":"Cell Signal"},{"key":"595_CR14","doi-asserted-by":"crossref","unstructured":"Hruban RH, Maitra A, Kern SE, Goggins M. Precursors to pancreatic cancer. Gastroenterol Clin North Am. 2007. 36(4): 831\u2009\u2013\u200949, vi.","DOI":"10.1016\/j.gtc.2007.08.012"},{"issue":"6","key":"595_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ccr.2012.10.025","volume":"22","author":"JL Kopp","year":"2012","unstructured":"Kopp JL, von Figura G, Mayes E, et al. Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;22(6):737\u201350.","journal-title":"Cancer Cell"},{"issue":"10","key":"595_CR16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s00018-022-04543-4","volume":"79","author":"Z Ming","year":"2022","unstructured":"Ming Z, Vining B, Bagheri-Fam S, Harley V. SOX9 in organogenesis: shared and unique transcriptional functions. Cell Mol Life Sci. 2022;79(10):522.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"595_CR17","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41467-023-44384-8","volume":"15","author":"S Puri","year":"2024","unstructured":"Puri S, Maachi H, Nair G, Russ HA, Chen R, Pulimeno P, et al. Sox9 regulates alternative splicing and pancreatic beta cell function. Nat Commun. 2024;15(1):588.","journal-title":"Nat Commun"},{"issue":"22","key":"595_CR18","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1089\/scd.2013.0106","volume":"22","author":"J Belo","year":"2013","unstructured":"Belo J, Krishnamurthy M, Oakie A, Wang R. The role of SOX9 transcription factor in pancreatic and duodenal development. Stem Cells Dev. 2013;22(22):2935\u201343.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"595_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1900\/RDS.2014.11.51","volume":"11","author":"PA Seymour","year":"2014","unstructured":"Seymour PA. Sox9: a master regulator of the pancreatic program. Rev Diabet Stud. 2014;11(1):51\u201383.","journal-title":"Rev Diabet Stud"},{"issue":"7","key":"595_CR20","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/onc.2017.393","volume":"37","author":"H Zhou","year":"2018","unstructured":"Zhou H, Qin Y, Ji S, et al. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. Oncogene. 2018;37(7):912\u201323.","journal-title":"Oncogene"},{"issue":"W1","key":"595_CR21","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98\u2013102.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"595_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13046-020-01823-4","volume":"40","author":"W Qian","year":"2021","unstructured":"Qian W, Chen K, Qin T, et al. The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer. J Exp Clin Cancer Res. 2021;40(1):25.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"595_CR23","doi-asserted-by":"publisher","first-page":"103647","DOI":"10.1016\/j.isci.2021.103647","volume":"25","author":"X Chen","year":"2022","unstructured":"Chen X, Sheng L, Ma J, et al. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone provokes progression from chronic pancreatitis to pancreatic intraepithelial neoplasia. iScience. 2022;25(1):103647.","journal-title":"iScience"},{"key":"595_CR24","doi-asserted-by":"publisher","first-page":"215976","DOI":"10.1016\/j.canlet.2022.215976","volume":"552","author":"W Zhang","year":"2023","unstructured":"Zhang W, Qian W, Gu J, et al. Mutant p53 driven-LINC00857, a protein scaffold between FOXM1 and deubiquitinase OTUB1, promotes the metastasis of pancreatic cancer. Cancer Lett. 2023;552:215976.","journal-title":"Cancer Lett"},{"issue":"1","key":"595_CR25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12943-017-0701-0","volume":"16","author":"K Chen","year":"2017","unstructured":"Chen K, Qian W, Jiang Z, et al. Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer. Mol Cancer. 2017;16(1):131.","journal-title":"Mol Cancer"},{"key":"595_CR26","doi-asserted-by":"crossref","unstructured":"Marstrand-Dauc\u00e9 L, Lorenzo D, Chassac A, Nicole P, Couvelard A, Haumaitre C. Acinar-to-Ductal Metaplasia (ADM): on the Road to Pancreatic Intraepithelial Neoplasia (PanIN) and pancreatic Cancer. Int J Mol Sci. 2023. 24(12).","DOI":"10.3390\/ijms24129946"},{"issue":"1","key":"595_CR27","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41392-021-00659-4","volume":"6","author":"S Wang","year":"2021","unstructured":"Wang S, Zheng Y, Yang F, et al. The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives. Signal Transduct Target Ther. 2021;6(1):249.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"595_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ceb.2007.02.004","volume":"19","author":"MT Bengoechea-Alonso","year":"2007","unstructured":"Bengoechea-Alonso MT, Ericsson J. SREBP in signal transduction: cholesterol metabolism and beyond. Curr Opin Cell Biol. 2007;19(2):215\u201322.","journal-title":"Curr Opin Cell Biol"},{"issue":"6","key":"595_CR29","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.ccell.2017.11.011","volume":"32","author":"Y Guri","year":"2017","unstructured":"Guri Y, Colombi M, Dazert E, et al. mTORC2 promotes tumorigenesis via lipid synthesis. Cancer Cell. 2017;32(6):807\u2013e82312.","journal-title":"Cancer Cell"},{"issue":"1","key":"595_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12964-023-01178-1","volume":"21","author":"D Zipinotti Dos Santos","year":"2023","unstructured":"Zipinotti Dos Santos D, de Souza JC, Pimenta TM, et al. The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape. Cell Commun Signal. 2023;21(1):161.","journal-title":"Cell Commun Signal"},{"issue":"3","key":"595_CR31","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41419-018-0330-6","volume":"9","author":"YA Wen","year":"2018","unstructured":"Wen YA, Xiong X, Zaytseva YY, et al. Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer. Cell Death Dis. 2018;9(3):265.","journal-title":"Cell Death Dis"},{"issue":"1","key":"595_CR32","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.molcel.2019.10.015","volume":"77","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Gu L, Lin X, et al. Dynamic regulation of ME1 phosphorylation and Acetylation affects lipid metabolism and colorectal tumorigenesis. Mol Cell. 2020;77(1):138\u2013e1495.","journal-title":"Mol Cell"},{"issue":"1","key":"595_CR33","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"3","key":"595_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: still emerging. Cell Metab. 2022;34(3):355\u201377.","journal-title":"Cell Metab"},{"issue":"1","key":"595_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41420-022-01213-z","volume":"8","author":"Y Wang","year":"2022","unstructured":"Wang Y, Zhang Y, Wang Z, et al. The interplay of transcriptional coregulator NUPR1 with SREBP1 promotes hepatocellular carcinoma progression via upregulation of lipogenesis. Cell Death Discov. 2022;8(1):431.","journal-title":"Cell Death Discov"},{"issue":"2","key":"595_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1530\/ERC-21-0256","volume":"29","author":"CY Kuo","year":"2021","unstructured":"Kuo CY, Chang YC, Chien MN, et al. SREBP1 promotes invasive phenotypes by upregulating CYR61\/CTGF via the Hippo-YAP pathway. Endocr Relat Cancer. 2021;29(2):47\u201358.","journal-title":"Endocr Relat Cancer"},{"key":"595_CR37","doi-asserted-by":"crossref","unstructured":"Chen TC, Huang CW, Lo CY, Chen CN, Chang SF, Chen YY. Suppression of SREBP-1 expression by Simvastatin decreases Visfatin-Induced Chemoresistance to Sunitinib in Human Renal Carcinoma 786-O cells. Life (Basel). 2022. 12(11).","DOI":"10.3390\/life12111890"},{"issue":"6","key":"595_CR38","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s12015-021-10232-9","volume":"17","author":"R Dettmer","year":"2021","unstructured":"Dettmer R, Niwolik I, Mehmeti I, J\u00f6rns A, Naujok O. New hPSC SOX9 and INS Reporter Cell Lines facilitate the Observation and optimization of differentiation into insulin-producing cells. Stem Cell Rev Rep. 2021;17(6):2193\u2013209.","journal-title":"Stem Cell Rev Rep"},{"issue":"2","key":"595_CR39","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1245\/s10434-018-6925-4","volume":"26","author":"JL Gnerlich","year":"2019","unstructured":"Gnerlich JL, Ding X, Joyce C, et al. Increased SOX9 expression in Premalignant and malignant pancreatic neoplasms. Ann Surg Oncol. 2019;26(2):628\u201334.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"595_CR40","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.humpath.2013.10.008","volume":"45","author":"S Shroff","year":"2014","unstructured":"Shroff S, Rashid A, Wang H, et al. SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. Hum Pathol. 2014;45(3):456\u201363.","journal-title":"Hum Pathol"},{"key":"595_CR41","doi-asserted-by":"crossref","unstructured":"Kawamura S, Matsushita Y, Kurosaki S et al. Inhibiting SCAP\/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis. J Clin Invest. 2022. 132(11).","DOI":"10.1172\/JCI151895"},{"issue":"5","key":"595_CR42","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1002\/2211-5463.13137","volume":"11","author":"Y Jin","year":"2021","unstructured":"Jin Y, Chen Z, Dong J, et al. SREBP1\/FASN\/cholesterol axis facilitates radioresistance in colorectal cancer. FEBS Open Bio. 2021;11(5):1343\u201352.","journal-title":"FEBS Open Bio"},{"issue":"8","key":"595_CR43","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41419-021-03999-9","volume":"12","author":"TB Wang","year":"2021","unstructured":"Wang TB, Geng M, Jin H, et al. SREBP1 site 1 protease inhibitor PF-429242 suppresses renal cell carcinoma cell growth. Cell Death Dis. 2021;12(8):717.","journal-title":"Cell Death Dis"},{"issue":"1","key":"595_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2049-3002-1-3","volume":"1","author":"B Griffiths","year":"2013","unstructured":"Griffiths B, Lewis CA, Bensaad K, et al. Sterol regulatory element binding protein-dependent regulation of lipid synthesis supports cell survival and tumor growth. Cancer Metab. 2013;1(1):3.","journal-title":"Cancer Metab"},{"issue":"7","key":"595_CR45","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41556-018-0122-3","volume":"20","author":"KC Patra","year":"2018","unstructured":"Patra KC, Kato Y, Mizukami Y, et al. Mutant GNAS drives pancreatic tumourigenesis by inducing PKA-mediated SIK suppression and reprogramming lipid metabolism. Nat Cell Biol. 2018;20(7):811\u201322.","journal-title":"Nat Cell Biol"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-025-00595-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-025-00595-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-025-00595-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T00:26:17Z","timestamp":1736814377000},"score":1,"resource":{"primary":{"URL":"https:\/\/biologydirect.biomedcentral.com\/articles\/10.1186\/s13062-025-00595-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,14]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["595"],"URL":"https:\/\/doi.org\/10.1186\/s13062-025-00595-1","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,14]]},"assertion":[{"value":"24 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}